View More Recent Stories

May 24, 2023 04:30PM Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results
Apr 27, 2023 08:04AM Novo Integrated Sciences (NVOS) Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000
Apr 27, 2023 08:00AM Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000
Apr 3, 2023 05:20PM Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results
Mar 24, 2023 09:00AM Novo Integrated Sciences Provides Update on Certain Current Actions and Events
Jan 30, 2023 04:30PM Novo Integrated Sciences (NVOS) Receives Nasdaq Non-compliance Notice
Jan 30, 2023 04:30PM Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
Jan 17, 2023 09:25AM Novo Integrated Sciences Provides Update on Certain Current Actions and Events
Dec 21, 2022 04:31PM Novo Integrated Sciences (NVOS) Receives Nasdaq Non-compliance Notice
Dec 21, 2022 04:30PM Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
Nov 30, 2022 08:00AM Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
Nov 8, 2022 08:00AM Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.
Oct 25, 2022 08:00AM Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions
Oct 12, 2022 08:00AM Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread
Jul 14, 2022 04:05PM Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
Jul 11, 2022 04:05PM Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
Jun 23, 2022 08:00AM Novo Integrated Sciences’ Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond
Apr 26, 2022 08:00AM Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
Apr 13, 2022 04:05PM Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
Apr 7, 2022 08:00AM Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
Mar 29, 2022 08:07AM Novo Integrated Sciences (NVOS) Signs MOU with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
Mar 29, 2022 08:00AM Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
Mar 24, 2022 08:03AM Novo Integrated Sciences (NVOS) Announces PRO-DIP US Patent for Oral Pouch Delivery System Technology
Mar 24, 2022 08:00AM Novo Integrated Sciences’ PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
Mar 23, 2022 08:00AM Novo Integrated Sciences (NVOS) Acquires Clinical Consultants International
Mar 23, 2022 08:00AM Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
Mar 16, 2022 08:00AM Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
Mar 8, 2022 08:00AM Novo Integrated Sciences’ IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada
Feb 18, 2022 08:00AM Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
Jan 18, 2022 04:09PM Novo Integrated Sciences (NVOS) Reports Q1 Revenue of $3.16M, Net Loss of $1.8M
Jan 18, 2022 04:05PM Novo Integrated Sciences Reports First Quarter Financial Results
Jan 14, 2022 08:03AM Novo Integrated Sciences (NVOS) Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
Jan 14, 2022 08:00AM Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
Dec 23, 2021 08:00AM Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
Dec 14, 2021 06:23PM Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
Nov 30, 2021 08:07AM Novo Integrated Sciences (NVOS) Acquires 91% Stake in Terragenx and its Intellectual Property of Approved Water-Soluble Iodine Micro-Nutrient
Nov 30, 2021 08:00AM Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
Oct 14, 2021 08:00AM Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
Sep 23, 2021 08:00AM Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th
Sep 14, 2021 07:54AM Novo Integrated Sciences CEO to Present at Virtual Webinar Hosted by 154 Agency
Aug 30, 2021 08:03AM Novo Integrated Sciences (NVOS) Announces LOIs to Acquires 7 Pharmacies in the US
Aug 30, 2021 08:00AM Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
Aug 18, 2021 08:00AM Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East
View More Recent Stories